A Study of Use of Ella®, an Emergency Contraceptive, Under Simulated OTC Conditions

Completed · Phase 3

Conditions studied: Emergency Contraception

In brief

This study is designed to assess whether consumers select and use ella® (ulipristal acetate 30mg), an emergency contraceptive, in a manner consistent with the OTC package directions in an OTC-like setting.

Key facts

Study ID

NCT03208985

Run by

HRA Pharma

People needed

1270

Starts

2017-05-23

Expected to finish

2018-06-14

Last updated by the study team

2022-12-02

Who can join

Age: any. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women who are self-pay or who are willing to be self-pay for the purposes of the study and who present for emergency contraception only for their own use

You may not qualify if…

• Cannot read, speak and understand English
• Cannot see well enough to read information on the label

Where it is running

• HRA Pharma Investigational Site — Rancho Cucamonga, California, United States
• HRA Pharma Investigational Site — Boulder, Colorado, United States
• HRA Pharma Investigational Site — Denver, Colorado, United States
• HRA Pharma Investigational Site — Denver, Colorado, United States
• HRA Pharma Investigational Site — Fort Myers, Florida, United States
• HRA Pharma Investigational Site — Miami, Florida, United States
• HRA Pharma Investigational Site — Orlando, Florida, United States
• HRA Pharma Investigational Site — Pembroke Pines, Florida, United States
• HRA Pharma Investigational Site — St. Petersburg, Florida, United States
• HRA Pharma Investigational Site — Tampa, Florida, United States
• HRA Pharma Investigational Site — Belleville, Illinois, United States
• HRA Pharma Investigational Site — Andover, Minnesota, United States
• HRA Pharma Investigational Site — Saint Louis Park, Minnesota, United States
• HRA Pharma Investigational Site — City of Saint Peters, Missouri, United States
• HRA Pharma Investigational Site — Kansas City, Missouri, United States
• HRA Pharma Investigational Site — Manchester, Missouri, United States
• HRA Pharma Investigational Site — St Louis, Missouri, United States
• HRA Pharma Investigational Site — St Louis, Missouri, United States
• HRA Pharma Investigational Site — Las Vegas, Nevada, United States
• HRA Pharma Investigational Site — Hackensack, New Jersey, United States
• HRA Pharma Investigational Site — Morristown, New Jersey, United States
• HRA Pharma Investigational Site — New Brunswick, New Jersey, United States
• HRA Pharma Investigational Site — Trenton, New Jersey, United States
• HRA Pharma Investigational Site — Albuquerque, New Mexico, United States
• HRA Pharma Investigational Site — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.